What is MPS Pharmaa Ltd (531686) share price return in the past 10 years?

MPS Pharmaa Ltd share price has declined -12.1% annually (CAGR) over the past ten years.

What is the share price of MPS Pharmaa Ltd (531686)?

Company share prices are keep on changing according to the market conditions. The current trading price of MPS Pharmaa Ltd (531686) on 01-Jun-2026 16:59:59 at 16:59 is 1.73.

What is the P/E ratio of MPS Pharmaa?

The latest standalone P/E ratio of MPS Pharmaa as of 01-Jun-2026 is 0.00.

What is the P/B ratio of MPS Pharmaa Ltd (531686)?

The latest standalone P/B ratio of MPS Pharmaa Ltd (531686) as of 01-Jun-2026 is 54.40.

What is the 52-week high and low of MPS Pharmaa Ltd (531686)?

The 52-week high of MPS Pharmaa Ltd (531686) is Rs. 3.01 and the 52-week low is Rs. 1.57.

MPS Pharmaa Ltd (531686) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: MPS Pharmaa Ltd (531686)
Brand: MPS Pharmaa

MPS Pharmaa Ltd (531686)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531686 NSE: Pharmaceuticals & Drugs | Small Cap | MPS Pharmaa Share Price

MPS Pharmaa Ltd (531686)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531686 NSE: Pharmaceuticals & Drugs | Small Cap | MPS Pharmaa Share Price

Key Metrics

Valuation Multiples

Market Cap

₹3 Cr.

Current Price

₹1.7

52-Week Low / High

₹2 / 3

TTM EPS

₹-0.5

TTM Sales

₹0 Cr.

Book Value per Share

P/E Ratio

0.00

Industry PE

46.5

Price to Book (P/B)

54.40

Higher than its 5-year historical median

Price to Sales (P/S)

0.00

EV/EBITDA

-11.90

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-58.89%

Underperforms industry median

Return on Capital Employed (ROCE)

-9.70%

Underperforms industry median

Return on Assets (ROA)

-9.32%

Operating Profit Margin

Net Profit Margin

Gross Profit Margin

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

35.89%

Pledged shares (%) of Promoter's holding (%)

16.04%

Reserves

₹-19 Cr.

Equity

₹19.1 Cr.

Face Value

₹10

All Time Low / High

₹0.32 / 53.25

MPS Pharmaa stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is MPS Pharmaa Ltd a good quality company?

MPS Pharmaa Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does MPS Pharmaa Ltd performance compare with that of its Peers?

Q.1 Revenue growth of MPS Pharmaa Ltd vs industry peers?

MPS Pharmaa Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of MPS Pharmaa Ltd?

Promoters hold 35.89% of the MPS Pharmaa Ltd, with 16.04% of their stake pledged, indicating high pledge risk.

Q.1 Stock return of MPS Pharmaa Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -14.1% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-4.2%	-33.9%	-5.9%	-7.8%	-8.1%	-36.9%	-9.6%	-11.2%	-9.1%	-9.7%	-
Value Creation Index ⓘ	-1.3	-3.4	-1.4	-1.6	-1.6	-3.6	-1.7	-1.8	-1.7	-1.7	-
Growth Parameters ⓘ
Sales ⓘ	1.4	2.8	4.1	0.8	0	0	0	0	0	0	0
Sales YoY Gr.	-	110.4%	44%	-79.7%	-100%	NA	NA	-100%	NA	NA	-
Adj EPS ⓘ	-0.6	-3.9	-0.5	-0.7	-0.6	-2.4	-0.1	-0.6	-0.4	-0.5	-0.5
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	9.9	6.1	5.6	5	4.4	2.1	2	1.5	1	0.6	0
Adj Net Profit ⓘ	-1.2	-7.4	-0.9	-1.3	-1.2	-4.5	-0.1	-1.1	-0.8	-0.9	-1
Cash Flow from Ops. ⓘ	1.3	0.4	-0.3	0.6	-0.5	-0.9	-4.3	-0.9	-0.6	-0.6	-
Debt/CF from Ops. ⓘ	5.3	17.9	-19.5	10.5	-12.8	-6.1	-1.3	-7.8	-11.5	-13.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-100%	NA	-100%	NA
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	-27.2%	-33.5%	-34.2%	-44.7%
Share Price	-12.1%	11.4%	-7.7%	-34.2%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-6.2	-48.3	-7.7	-12.3	-13	-73.7	-3.6	-31.8	-34.9	-58.9	-176.7
Op. Profit Mgn % ⓘ	-36.4	-242	-12.8	-86.8	-15362.1	0	-2079.4	0	0	0	NAN
Net Profit Mgn % ⓘ	-87.9	-259.8	-21.1	-150.5	-26692.7	0	-437.3	0	0	0	-INF
Debt to Equity ⓘ	0.4	0.6	0.6	0.7	0.8	1.4	1.5	2.4	3.7	6.9	0
Working Cap Days ⓘ	4,113	1,300	621	2,611	4,39,267	0	23,660	0	0	0	0
Cash Conv. Cycle ⓘ	3,209	1,017	413	1,651	2,62,890	0	9,803	0	0	0	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	1.35	2.84	4.09	0.83	0	0	0.03	0	0	0
Operating Expenses ⓘ +	1.85	9.72	4.62	1.55	0.68	4.13	0.71	0.95	0.80	0.76
Manufacturing Costs	0.18	0.29	0.15	0.05	0.06	0.07	0.06	0.21	0.07	0.06
Material Costs	0.41	8.22	3.51	0.82	0	0	0.05	0.04	0	0
Employee Cost	0.78	0.79	0.65	0.49	0.45	0.40	0.42	0.49	0.53	0.52
Other Costs ⓘ	0.47	0.42	0.30	0.18	0.17	3.66	0.18	0.21	0.20	0.18
Operating Profit ⓘ	-0.49	-6.88	-0.53	-0.72	-0.67	-4.13	-0.67	-0.95	-0.80	-0.76
Operating Profit Margin (%)	-36.4%	-242.0%	-12.8%	-86.8%	-15,422.5%	-	-2,079.4%	-	-	-
Other Income ⓘ +	0	0.03	0.06	0.02	0.01	0.20	0.26	0.02	0.09	0.05
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.08	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	0.62	0.59	0.59	0.59	0.57	0.56	0.51	0.15	0.15	0.15
Profit Before Tax ⓘ	-1.20	-7.44	-1.06	-1.29	-1.24	-4.49	-0.93	-1.07	-0.85	-0.86
Tax ⓘ	-0.01	-0.06	-0.19	-0.05	-0.07	-0.08	-0.79	-0.02	-0.02	0.03
Profit After Tax	-1.19	-7.39	-0.87	-1.25	-1.17	-4.42	-0.14	-1.05	-0.83	-0.90
PAT Margin (%)	-87.9%	-259.0%	-21.1%	-150.0%	-26,735.0%	-	-437.0%	-	-	-
Adjusted EPS (₹)	-0.6	-3.9	-0.5	-0.7	-0.6	-2.3	-0.1	-0.6	-0.4	-0.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of MPS Pharmaa - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	18.98	11.61	10.76	9.53	8.36	3.95	3.83	2.79	1.97	1.08
Share Capital ⓘ	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11	19.11
Reserves ⓘ	-0.13	-7.50	-8.35	-9.58	-10.75	-15.16	-15.29	-16.32	-17.14	-18.03
Debt +	3.87	2.90	2.90	2.51	2.54	1.93	5.81	6.76	7.27	7.46
Long Term Debt	0.98	0	0	0	0	0	0	0	0	0
Short Term Debt	2.90	2.90	2.90	2.51	2.54	1.93	5.81	6.76	7.27	7.46
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.64	0.36	0.14	0.16	0.15	0.09	0.12	0.20	0.20	0.20
Others Liabilities ⓘ	5.08	6.06	5.36	5.36	5.37	5.33	0.40	0.43	0.49	0.59
Total Liabilities ⓘ	28.57	20.93	19.15	17.56	16.41	11.30	10.16	10.19	9.94	9.33
Fixed Assets
Net Fixed Assets ⓘ +	7.64	7.06	6.47	5.88	5.26	4.68	4.17	4.14	4.01	3.83
Gross Block	16.15	16.16	16.16	16.16	16.05	15.71	15.72	15.84	15.86	15.17
Accumulated Depreciation	8.51	9.10	9.69	10.28	10.79	11.04	11.55	11.70	11.84	11.33
CWIP ⓘ	6.15	5.51	5.21	5.43	5.02	3.90	3.42	3.40	3.26	2.91
Investments ⓘ	0.92	0.92	0.92	0.92	0.92	0.54	0.54	0.54	0.54	0.54
Inventories	7.53	1.13	0.57	0.57	0.57	0.57	0.55	0.50	0.50	0.50
Trade Receivables	4.27	4.14	3.86	2.61	2.53	0.59	0.03	0.03	0.02	0.01
Cash Equivalents	0.03	0.06	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0
Others Assets ⓘ	2.03	2.11	2.11	2.12	2.09	1.02	1.43	1.57	1.60	1.53
Total Assets ⓘ	28.57	20.93	19.15	17.56	16.41	11.30	10.16	10.19	9.94	9.33

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	1.25	0.37	-0.34	0.60	-0.49	-0.93	-4.34	-0.87	-0.63	-0.57
PBT ⓘ	-1.20	-7.43	-1.06	-1.29	-1.24	-4.49	-0.56	-1.05	-0.84	-0.88
Adjustment ⓘ	0.74	0.61	0.62	0.60	0.59	0.58	0.51	0.15	0.15	0.15
Changes in Working Capital ⓘ	1.89	7.2	0.1	1.29	0.15	2.98	-4.3	0.04	0.06	0.17
Tax Paid ⓘ	-0.18	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-0.05	0.63	0.30	-0.21	0.46	1.54	0.46	-0.10	0.12	0.38
Capex	-0.05	0.63	0.30	-0.22	0.05	0.03	-0.01	-0.12	-0.02	0.03
Net Investments	0	0	0	0	0	0.39	0	0	0	0
Others ⓘ	0	0	0	0.01	0.41	1.13	0.47	0.02	0.14	0.35
Cash Flow From Financing Activity ⓘ +	-1.19	-0.98	-0	-0.39	0.03	-0.61	3.88	0.96	0.51	0.18
Net Proceeds from Shares ⓘ	0.97	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.98	-0.98	0	-0.39	0.03	-0.61	3.88	0.96	0.51	0.18
Interest Paid ⓘ	-0.08	-0	-0	-0	-0	-0	-0	-0	-0	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-1.10	0	0	0	0	-0	0	-0	0	-0
Net Cash Flow ⓘ	0.01	0.02	-0.04	0	-0	0	0	-0.01	-0	-0

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-6.79	-48.3	-7.74	-12.28	-13.04	-71.73	-3.64	-31.75	-34.92	-58.89
ROCE (%)	-4.23	-33.9	-5.91	-7.76	-8.08	-36.9	-9.64	-11.15	-9.06	-9.7
Asset Turnover Ratio	0.04	0.12	0.2	0.05	0	0	0	0	0	0
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	1,592	515.50	356.60	1,425.90	0	0	3,546.50	0	0	0
Inventory Days	1,982.50	530.70	76.10	252.50	0	0	6,293.90	0	0	0
Payable Days	1,757.80	22.40	26	66.40	0	0	769.80	1,303.80	0	0

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

16.04

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

MPS Pharmaa Ltd FAQs

The current trading price of MPS Pharmaa on 01-Jun-2026 16:59 is ₹1.73.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-May-2026 the market cap of MPS Pharmaa stood at ₹3.31 Cr

The latest P/E ratio of MPS Pharmaa as of 31-May-2026 is 0.00.

The latest P/B ratio of MPS Pharmaa as of 31-May-2026 is 54.40.

The 52-week high of MPS Pharmaa is ₹3.01 and the 52-week low is ₹1.57.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of MPS Pharmaa is ₹0.00 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that MPS Pharmaa Ltd is a below average quality company.

The key valuation ratios of MPS Pharmaa Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of MPS Pharmaa Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About MPS Pharmaa Ltd

Advik Laboratories has been set up by V K Jain, a qualified production chemist with over 20 years experience in pharmaceutical products.

Advik Laboratories was established in the 1994. It is WHO-GMP certified company that has been set up from the ground level with the avowed objective of achieving USFDA standards of quality.

The company has a technical collaboration with PFC Pharma Focus of Switzerland. It enjoys leadership status at various fronts such as high product quality, a growing range of products, state of the art manufacturing process, competitive pricing and customer service. In addition the company exports a wide range of drugs to the Middle East, South America and Africa.

The product range includes ethical, generic drugs and over the counter drugs (OTC) in various formulations.

With over 60,000 square feet of built-up area, ample developed open space around it, a state-of-the-art manufacturing facility, the ground floor has provisions for the production and in-process control section for the manufacturing of steroidal & non-steroidal formulations, change room for gents & ladies and stores for raw & packing materials. The first floor has provision for the production and in-process control section for the manufacturing of ampicillin and non-ampicillin capsules and dry syrup preparations. The second floor has provision for quality control and about 12000 sq ft area is presently being reserved for the manufacture of injectables & ointments in the second phase.

Advik Laboratories provides pharmaceutical formulations that match the international standards of quality. The facility manufactures a wide range of pharmaceuticals formulations in tablets, capsules and dry syrups.

Products - Under Ethical products, the company manufactures Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin and Chewfe-C.

Under generic products, the company manufactures drugs catering segment such as antibacterials, antiallergics, antifungals, analgesic, antipyretic and anti-inflammatory, anti-hypertensives, anthelminthics, anti-malarials, corticosteroids, erectile dysfunction, gastrointestinal agents and sedatives.

Award - Advik Laboratories has received the prestigious Udyog Patra Award from the Government of India in 1999.

MPS Pharmaa Ltd (531686)

MPS Pharmaa Ltd (531686)

MPS Pharmaa stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of MPS Pharmaa - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

MPS Pharmaa Ltd FAQs

About MPS Pharmaa Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

MPS Pharmaa Ltd (531686)

MPS Pharmaa Ltd (531686)

MPS Pharmaa stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of MPS Pharmaa - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

MPS Pharmaa Ltd FAQs

What is the share price of MPS Pharmaa?

What is the market cap of MPS Pharmaa?

What is the P/E ratio of MPS Pharmaa?

What is the P/B ratio of MPS Pharmaa?

What is the 52-week high and low of MPS Pharmaa?

What is the TTM revenue of MPS Pharmaa?

Is MPS Pharmaa Ltd a good quality company?

Is MPS Pharmaa Ltd undervalued or overvalued?

Is MPS Pharmaa Ltd a good buy now?

About MPS Pharmaa Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.